An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Pulmonx Corporation
Study ID
NCT06035120
Status
Recruiting

Conditions

  • Emphysema or COPD
  • Emphysema, Pulmonary

Eligibility Criteria

Sex
ALL
Age
40 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • AeriSeal System — DEVICE
    The AeriSeal System comprises AeriSeal Foam and the AeriSeal Balloon Catheter Preparation Kit that is used for bronchoscopic delivery of AeriSeal Foam to the targeted regions of the lung.

Study Details

This is a prospective, open-label, multi-center, single-arm study planned to enroll 200 subjects with heterogeneous emphysema and collateral ventilation (CV) in the target lobe. Subjects will undergo instillation of AeriSeal Foam in the target lobe and subsequent assessment of CV status using Chartis Pulmonary Assessment System. Subjects with CV- status will then undergo placement of Zephyr Valve in the target lobe for bronchoscopic lung volume reduction (BLVR) and be followed for 24 months.

Key Dates

Start date
Feb 22, 2024
Status verified
Mar 2026
Primary completion
Jun 30, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: AeriSeal
    All enrolled subjects meeting final eligibility will undergo the AeriSeal procedure to block collateral ventilation by closing the lobar fissure gaps or collateral air channels.

Primary Outcome Measure

Converters, responder rate [ Time Frame: 45 days post-AeriSeal treatment (index or repeat) ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
Banner University Medical CenterPhoenixArizona85006
Maria Masters
602-827-2363
Raed Alalawi, MD
Raed Alalawi, MD (PRINCIPAL_INVESTIGATOR)
Saint Francis Hospital and Medical Center (Trinity Health of New England)HartfordConnecticut06105
Kendra Williams
860-714-7161
Amber Newman
860-714-4055
Anil Magge, MD (PRINCIPAL_INVESTIGATOR)
Orlando HealthOrlandoFlorida32806
Donya Shahnavaz
321-841-7303
Mark Vollenweider, MD
Mark Vollenweider, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Adriana Martinez
312-926-6680
Momen Wahidi, MD
Momen Wahidi, MD (PRINCIPAL_INVESTIGATOR)
University of Chicago Medical CenterChicagoIllinois60637
Jessica Tuck
773-795-4434
Ajay Wagh, MD
Ajay Wagh, MD (PRINCIPAL_INVESTIGATOR)
OSF Saint Francis Medical CenterPeoriaIllinois61606
Kimberly Hartwig
309-655-4229
Patrick Whitten, MD
Patrick Whitten, MD (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02115
Maria Lopez Giron
786-967-8448
Adnan Majid, MD
Adnan Majid, MD (PRINCIPAL_INVESTIGATOR)
Brigham Lung CenterBostonMassachusetts02115-
Henry Ford HospitalDetroitMichigan48202
Ruth George
313-916-1791
Avi Cohen, MD (PRINCIPAL_INVESTIGATOR)
Cleveland VA NortheastClevelandOhio44106-
Penn MedicinePhiladelphiaPennsylvania19107
Katelyn Lobo
215-615-0132
Kevin Ma, MD
Kevin Ma, MD (PRINCIPAL_INVESTIGATOR)
Temple UniversityPhiladelphiaPennsylvania19140
Helga Criner
215-707-1559
Gerard Criner
Gerard Criner, MD (PRINCIPAL_INVESTIGATOR)
Allegheny General HospitalPittsburghPennsylvania15212
Paige Rutter
412-295-7659
Stephanie Baltaji, MD
Stephanie Baltaji, MD (PRINCIPAL_INVESTIGATOR)
University of Pittsburgh Medical Center (UPMC)PittsburghPennsylvania15213
Paula Consolaro
412-605-1904
Frank Sciurba, MD
Frank Sciurba, MD (PRINCIPAL_INVESTIGATOR)
Fort Sanders Regional Medical Center (StatCare)KnoxvilleTennessee37916
Jennifer Thornton
865-588-8831
Varun Shah, MD
Varun Shah, MD (PRINCIPAL_INVESTIGATOR)
University of Texas SouthwesternDallasTexas75235
Khyati Vadera
214-645-8464
Muhanned Abu-Hijleh, MD
Muhanned Abu-Hijleh, MD (PRINCIPAL_INVESTIGATOR)
Inova Fairfax HospitalFalls ChurchVirginia22042
Alma Khan
703-776-5912
Priya Patel, MD
Priya Patel, MD (PRINCIPAL_INVESTIGATOR)
Medical College of Wisconsin (MCW)MilwaukeeWisconsin53226
Sam Servi
414-955-7030
Jonathan Kurman, MD
Jonathan Kurman, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

Related Studies